News

Elixir Medical Announces Positive Nine-Month Results from the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study

Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent

Events

Presentations at Transcatheter Cardiovascular Therapeutics 2007, Washington DC

Session: First-in-Man Experiences with Drug-Eluting Stents: Passive and Active Stent Coatings